Company / Current Liabilities
MADRIGAL PHARMACEUTICALS, INC. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$310.3M
FY2025
5-year range
$76.8M / $310.3M
FY2021-FY2025
Trend
+83.3%
vs FY2024
Sector context
#44 of 213
Health Care
What the data says
MADRIGAL PHARMACEUTICALS, INC.'s current liabilities of $310M is higher than 79% of companies in the Health Care sector (FY2025). Current Liabilities has increased for 7 consecutive years, from $8M in FY2018 to $310M in FY2025.
Based on SEC 10-K filings.
$310M in FY2025 with a 5-year CAGR of +46.1%. Top quartile in the Health Care sector.
Increased from $119M to $310M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +38.9%
- 5-Year CAGR
- +46.1%
- 10-Year CAGR
- -
Sector benchmark
-80.5% below sector average
Key checks
Key Insights
- MADRIGAL PHARMACEUTICALS, INC.'s current liabilities has grown for 7 consecutive years.
- 5-year CAGR of +46.1%, indicating consistent growth.
- In FY2025, current liabilities increased 83.3% year-over-year.
- Ranks #44 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $310.3M | +83.3% |
| FY2024 | $169.3M | +42.8% |
| FY2023 | $118.5M | +2.3% |
| FY2022 | $115.9M | +50.8% |
| FY2021 | $76.8M | +65.0% |
| FY2020 | $46.6M | +85.3% |
| FY2019 | $25.1M | +197.6% |
| FY2018 | $8.4M | -16.0% |
| FY2017 | $10.1M | +109.5% |
| FY2016 | $4.8M | -84.5% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026